Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study. - Wikidata - awgldk - TriplyDB

Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

http://www.wikidata.org/entity/Q30990623

about

Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study Sarcopenia is associated with disability status-results from the KORA-Age study.Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly.Frailty and exercise interventions : Evidence and barriers for exercise programs.Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap!The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation.Developing sarcopenia criteria and cutoffs for an older Caucasian cohort - a strictly biometrical approach

P2860

Q37441579-C4A7BBB3-D2FF-4C2B-99C9-3747CDADD1E1 Q38848721-E48156CF-C0E4-4875-BF91-AEE017689062 Q38944736-4177B013-F84A-44A8-BA8A-E5B0674C628F Q38961323-5D22927E-CA05-453F-A340-6CCD7B710A1C Q47433723-425C956A-621A-4162-8B10-68DD89219416 Q50915075-A2C2E6DD-F27A-4188-A223-861C39E4C72E Q58803522-76B4B786-E219-4323-B5C9-439F41BB1E3F

P2860

Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.

http://www.wikidata.org/entity/Q30990623

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@ast

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@en

type

label

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@ast

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@en

prefLabel

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@ast

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@en

P1433

Q30990623-22D45DEA-6A63-4F97-A275-99C4D9E6E79C

P1476

Q30990623-23A288FA-77A2-485C-AE07-ED536628800D

P2093

Q30990623-06DEA258-6EDC-485C-A289-0A8E182B49B6

Q30990623-77C5AFE4-B1A1-489F-A6F0-3FD2F03157F9

Q30990623-93599245-6442-4C35-9D7A-BA265C65821E

Q30990623-BA392E6F-71BA-42C3-81A0-EA755F6F00D9

Q30990623-C1DAC0F4-DF46-4010-9FDA-3092A4E6375E

P2860

Q30990623-009ED5FC-A071-42BB-87CC-360856F89894

Q30990623-03199BCD-B57C-4C65-8C3F-4274B6EC7445

Q30990623-039FD1DB-7161-4856-BE90-084BF883B804

Q30990623-11119BD1-329D-42AB-8147-B7252B298C44

Q30990623-1D3212B3-C374-48AB-B7D7-6D86969CC9D9

Q30990623-4946D2E4-EE15-4EC0-BD57-27DFB7636A82

Q30990623-54BE7862-F1EB-444B-8FDD-866CE15F2AE7

Q30990623-561BB184-BFA2-438C-8986-2FF7BD33F947

Q30990623-5A9FB03F-E60B-4449-873A-F08EF2534831

Q30990623-64590C20-2AC9-45E1-B7A6-7D39EA765D03

P2888

Q30990623-B32DDFE3-7202-4393-A0A4-FA01905B4F04

P304

Q30990623-3E355913-EF94-416A-931C-887E7FB15793

P31

Q30990623-8DE70E88-5E01-4143-BA2E-8F1C79D36D30

P356

Q30990623-60E5FF7C-66CD-4672-9CC7-94F4F0685B48

P407

Q30990623-E377F8DD-0E27-4191-B228-729BED91F2C1

P433

Q30990623-4DD364AE-366E-4CE3-B0C9-646C1D78083A

P478

Q30990623-4A301723-849A-485D-8B81-325849B9EE34

P577

Q30990623-9CEE0791-F224-4F23-AA23-C8AAB2431AFE

P5875

Q30990623-B96DD375-04B1-42C1-ABA5-0DDEC7F2CC8D

P698

Q30990623-0D2E1C8C-3A81-4699-B013-363C4E5D3A3D

P921

Q30990623-20AE0260-757C-4D2A-897C-1575DD3B403B

Q30990623-40338967-EE2F-4C01-A40F-5A4D90504EF6

P356

S00198-015-3303-Y

P1433

Osteoporosis International

P1476

Prevalence of sarcopenic obesi ...... ine data of the FORMOsA study.

@en

P2093

C Sieber

http://www.w3.org/2001/XMLSchema#string

E Freiberger

http://www.w3.org/2001/XMLSchema#string

K Engelke

http://www.w3.org/2001/XMLSchema#string

S von Stengel

http://www.w3.org/2001/XMLSchema#string

W Kemmler

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

Sarcopenic obesity: how do we treat it?

Epidemiology of sarcopenia among the elderly in New Mexico

Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004.

Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study.

Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).

Walking speed in elderly outpatients depends on the assessment method

Sarcopenic obesity: a new category of obesity in the elderly.

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia

The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.

P2888

s00198-015-3303-y

P304

275-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-015-3303-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281484230

http://www.w3.org/2001/XMLSchema#string

P698

26318759

http://www.w3.org/2001/XMLSchema#string

P921